C.P. Carron
Department of Discovery Pharmacology
Searle Research and Development
Monsanto Company
St. Louis
USA
Name/email consistency: high
- A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy. Carron, C.P., Meyer, D.M., Pegg, J.A., Engleman, V.W., Nickols, M.A., Settle, S.L., Westlin, W.F., Ruminski, P.G., Nickols, G.A. Cancer Res. (1998)